Big Gain For PROG
PROG (PROG:NASDAQ) rocketted at $1.52, representing a gain of 40.7%. On Wed, Sep 29, 2021, PROG:NASDAQ touched a New 2-Week High of $1.08. The stock got featured on our News Catalysts scanner on Tue, Sep 21, 2021 at 07:46 AM in the 'PATNERSHIP' category. From Wed, Sep 15, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Sep 03, 2021 at $1.25 with a volume of 2B+.
About PROG (PROG:NASDAQ)
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
Top 10 Gainers:
- Conyers Park II Acquisition Corp. (CPAA:NASDAQ), 100%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 60.55%
- PROG (PROG:NASDAQ), 40.74%
- Farmmi, Inc. (FAMI:NASDAQ), 36.03%
- ALZN (ALZN:NASDAQ), 35.09%
- OG (OG:NYSE), 30%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 25.63%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 22.95%
- Mediaco Holding Inc. (MDIA:NASDAQ), 20.08%
- Epsilon Energy Ltd. (EPSN:NASDAQ), 18.38%